See All Slides - tctmd.com

Slides

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil

September 15, 2014

Presentation TCT 2014

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Presenter: Ian T. Meredith

September 15, 2014

Presentation TCT 2014

Lessons from the Nordic Trials: Summary of Trials and Data Gaps

Presenter: Jens Flensted Lassen, Thierry Lefevre, Issam D. Moussa, Leif Thuesen

September 15, 2014

Presentation TCT 2014

Comparative Analysis of Warfarin and the NOACs: Differentiating Properties, Risks, and Benefits

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, Jonathan L. Halperin

September 15, 2014

Presentation TCT 2014

Lotus Valve - Technology Review and Status of the US Clinical Trial

Presenter: Ted E. Feldman

September 15, 2014

Presentation TCT 2014

IVUS Assessment and DES-Guided Treatment of Left Main Lesions

Presenter: Patrick A. Calvert, Gary S. Mintz, Bernhard Witzenbichler, Jose M. de la Torre Hernandez

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Arne Schwindt

September 15, 2014

Presentation TCT 2014

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

Presenter: Saibal Kar

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Bo Xu

September 15, 2014

Presentation TCT 2014

TCT 149: Intracoronary Injection of Bone Marrow-Derived Mononuclear Cells, Early or Late After Acute Myocardial Infarction: Long-term Effects on Global Left Ventricular Function Twelve-Month MRI and Long-term Clinical Results of the SWISS-AMI Trial

Presenter: Jonathan M. Hill, Hyo-Soo Kim, Emerson C. Perin, Daniel Suerder, MD

September 15, 2014

Advertisement

Slides

Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent

TCT 696: One-Year Outcomes with the Fully Repositionable and Retrievable Lotus? Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study

Lessons from the Nordic Trials: Summary of Trials and Data Gaps

Comparative Analysis of Warfarin and the NOACs: Differentiating Properties, Risks, and Benefits

Lotus Valve - Technology Review and Status of the US Clinical Trial

IVUS Assessment and DES-Guided Treatment of Left Main Lesions

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

TCT 149: Intracoronary Injection of Bone Marrow-Derived Mononuclear Cells, Early or Late After Acute Myocardial Infarction: Long-term Effects on Global Left Ventricular Function Twelve-Month MRI and Long-term Clinical Results of the SWISS-AMI Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content